Stay updated on Dupilumab for AKC: Efficacy Study Clinical Trial
Sign up to get notified when there's something new on the Dupilumab for AKC: Efficacy Study Clinical Trial page.

Latest updates to the Dupilumab for AKC: Efficacy Study Clinical Trial page
- Check3 days agoChange DetectedThe new screenshot shows changes to study sites (additions and withdrawals) and updated enrollment status, with several locations now listed as Recruiting or Completed.SummaryDifference0.4%

- Check10 days agoNo Change Detected
- Check32 days agoChange Detected- Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference4%

- Check39 days agoChange DetectedUpdate: revision updated from v3.0.2 to v3.1.0 and a new contact phone number 978-332-9417 added.SummaryDifference0.1%

- Check53 days agoChange DetectedCore content updated from Revision: v3.0.1 to Revision: v3.0.2; the Back to Top element was removed.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%

- Check68 days agoChange DetectedThe web page has updated the facility name and location details, specifically replacing the previous location terms with more precise identifiers, including St. Louis and Town and Country, Missouri. Additionally, the medication 'dupilumab' has been added to the content.SummaryDifference3%

Stay in the know with updates to Dupilumab for AKC: Efficacy Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab for AKC: Efficacy Study Clinical Trial page.